Evidence map›Paper›PMID 22311367›Full record

ArticleDigestive diseases and sciences2012

ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.

Jennifer A Coukos, Lauren A Howard, Janice M Weinberg, James M Becker, Arthur F Stucchi, Francis A Farraye

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. The MYTHS ofJapanese journal of gastroenterology and hepatology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review article: the pathogenesis of pouchitis.Alimentary pharmacology & therapeutics · 2016
    Review
  13. The Immunological Basis of Inflammatory Bowel Disease.Gastroenterology research and practice · 2016
    Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer A CoukosDepartment of Medicine, Section of Gastroenterology, Boston Medical Center, Boston, MA 02118, USA. Jennifer.Coukos@bmc.org
Lauren A Howard
Janice M Weinberg
James M Becker
Arthur F Stucchi
Francis A Farraye
Boston Medical Center · USBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor ulcerative colitis (UC) patients undergoing ileal pouch-anal anastomosis (IPAA), postoperative complications include chronic pouchitis and development of Crohn's disease (CD) of the pouch.

aimsThe aim of this study was to determine if serologic markers obtained postoperatively are associated with the development of complications in UC patients after IPAA.

methodsA retrospective chart review was conducted of UC patients with IPAA were tested for expression of serologic markers. Complications abstracted from medical records included postoperative fistula, CD of the pouch, chronic pouchitis, and diversion or excision of the pouch.

results142 patients were enrolled, 44 of whom developed complications. Positive serologic profiles for ASCA IgG and anti-CBir1 markers were found to be associated with the development of any complication, (P = 0.017 and P = 0.002, respectively). A positive anti-CBir1 test was also found to be associated with CD of the pouch and/or fistula formation (P < 0.001). Similarly, both ASCA IgG and anti-CBir1 titers were significantly associated with postoperative IPAA complications (P = 0.034 and P = 0.001, respectively), and anti-CBir1 titers were associated with CD of the pouch and/or fistula formation (P < 0.001). Complications developed after a median follow-up of 216 months (range 1-264).

conclusionsASCA IgG and anti-CBir1 markers were associated with the development of complications after IPAA, specifically fistulae and/or CD of the pouch. The ability to identify patients at high risk for adverse outcomes may allow for early aggressive therapy, which may decrease the rate of pouch failure. A prospective study of patients with preoperative serology is ongoing.

Indexed as

AdolescentAdultAnastomosis, SurgicalAntibodies, Antineutrophil CytoplasmicBiomarkersChildChild, PreschoolCohort StudiesColitis, UlcerativeColonic PouchesConfidence IntervalsCrohn DiseaseEnzyme-Linked Immunosorbent AssayFemaleFlagellinFollow-Up StudiesAntibodies, Antineutrophil CytoplasmicBiomarkersCBir1 flagellinFlagellinImmunoglobulin G

Identifiers

PMID22311367
OpenAlexW2026415870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.